Clinical significance of SETBP1 expression in breast cancer.

被引：0
|
作者：
Ando, Yuki [1 ]
Masuda, Takaaki [1 ]
Hayashi, Naoki [2 ]
Mochizuki, Kenichi [1 ]
Abe, Tadashi [1 ]
Saito, Hideyuki [1 ]
Ozato, Yuki [1 ]
Nakano, Takafumi [1 ]
Koike, Kensuke [1 ]
Motomura, Yushi [1 ]
Takahashi, Junichi [1 ]
Toshima, Takeo [1 ]
Hisamatsu, Yuichi [1 ]
Yonemura, Yusuke [1 ]
Mimori, Koshi [1 ]
机构：
[1] Kyushu Univ, Beppu Hosp, Dept Surg, Beppu, Oita, Japan
[2] Kagoshima City Hosp, Dept Breast Surg, Kagoshima, Japan
来源：
CANCER SCIENCE | 2022年 / 113卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
J4-2-4
引用
收藏
页码：741 / 741
页数：1
相关论文
共 50 条
  • [21] Somatic SETBP1 mutations in myeloid neoplasms
    Makishima, Hideki
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2017, 105 (06) : 732 - 742
  • [22] SETBP1 is dispensable for normal and malignant hematopoiesis
    Tanaka, Atsushi
    Nishimura, Koutarou
    Saika, Wataru
    Kon, Ayana
    Koike, Yui
    Tatsumi, Hiromi
    Takeda, June
    Nomura, Masaki
    Zang, Weijia
    Nakayama, Manabu
    Matsuda, Masashi
    Yamazaki, Hiromi
    Fukumoto, Miki
    Ito, Hiromi
    Hayashi, Yasutaka
    Kitamura, Toshio
    Kawamoto, Hiroshi
    Takaori-Kondo, Akifumi
    Koseki, Haruhiko
    Ogawa, Seishi
    Inoue, Daichi
    LEUKEMIA, 2023, 37 (9) : 1802 - 1811
  • [23] SETBP1 is dispensable for normal and malignant hematopoiesis
    Atsushi Tanaka
    Koutarou Nishimura
    Wataru Saika
    Ayana Kon
    Yui Koike
    Hiromi Tatsumi
    June Takeda
    Masaki Nomura
    Weijia Zang
    Manabu Nakayama
    Masashi Matsuda
    Hiromi Yamazaki
    Miki Fukumoto
    Hiromi Ito
    Yasutaka Hayashi
    Toshio Kitamura
    Hiroshi Kawamoto
    Akifumi Takaori-Kondo
    Haruhiko Koseki
    Seishi Ogawa
    Daichi Inoue
    Leukemia, 2023, 37 : 1802 - 1811
  • [24] Recurrent SETBP1 Mutations in Atypical Chronic Myeloid Leukemia Abrogate an Ubiquitination Site and Dysregulate SETBP1 Protein Levels
    Gambacorti-Passerini, Carlo
    Valletta, Simona
    Winkelmann, Nils
    Redaelli, Sara
    Spinelli, Roberta
    Pirola, Alessandra
    Antolini, Laura
    Mologni, Luca
    Donadoni, Carla
    Papaemmanuil, Elli
    Schnittger, Susanne
    Dong-Wook, Kim
    Boultwood, Jacqueline
    Rossi, Fabio
    Gaipa, Giuseppe
    De Martini, Greta
    di Celle, Paola Francia
    Jang, Hyun G.
    Fantin, Valeria
    Bignell, Graham R.
    Magistroni, Vera
    Haferlach, Torsten
    Pogliani, Enrico Maria
    Campbell, Peter
    Chase, Andrew J.
    Tapper, William J.
    Cross, Nicholas C. P.
    Piazza, Rocco
    BLOOD, 2012, 120 (21)
  • [25] Myb expression is critical for myeloid leukemia development induced by Setbp1 activation
    Nhu Nguyen
    Vishwakarma, Bandana A.
    Oakley, Kevin
    Han, Yufen
    Przychodzen, Bartlomiej
    Maciejewski, Jaroslaw P.
    Du, Yang
    ONCOTARGET, 2016, 7 (52) : 86300 - 86312
  • [26] Functional significance of erythropoietin receptor expression in breast cancer.
    Haroon, ZA
    Amin, K
    Karayal, AF
    Cho, SC
    Raleigh, JA
    Varia, MA
    Arcasoy, MO
    BLOOD, 2001, 98 (11) : 300A - 301A
  • [27] Prognostic significance of FHIT protein expression in breast cancer.
    Depowski, PL
    Rosenthal, SI
    Brien, TP
    Croce, CM
    Ross, JS
    LABORATORY INVESTIGATION, 1999, 79 (01) : 19A - 19A
  • [28] The significance of the expression of KiSS-1 and its receptor in human breast cancer.
    Martin, TA
    Watkins, G
    Mansel, RE
    Jiang, WG
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S253 - S253
  • [29] Clinical Significance of Annexin A1 Expression in Breast Cancer
    Yom, Cha Kyong
    Han, Wonshik
    Kim, Sung-Won
    Kim, Hee Sung
    Shin, Hee-Chul
    Chang, Ji Na
    Koo, Minyoung
    Noh, Dong-Young
    Moon, Byung-In
    JOURNAL OF BREAST CANCER, 2011, 14 (04) : 262 - 268
  • [30] Correction to: Somatic SETBP1 mutations in myeloid neoplasms
    Hideki Makishima
    International Journal of Hematology, 2021, 114 : 742 - 742
12345